Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-1960144CALL0 1226.7TRUE00
2025-12-19650CALL0 0233.61TRUE00
2025-12-19700CALL0 0216.81TRUE00
2025-12-19750CALL0 0165.58TRUE00
2025-12-19800CALL0 00TRUE00
2025-12-1985131.3CALL0 1172.32TRUE00
2025-12-1990124.3CALL0 3174.4TRUE00
2025-12-19950CALL0 0171.85TRUE00
2025-12-191000CALL0 0150.56TRUE00
2025-12-1910589CALL0 1139.49TRUE00
2025-12-1911099.5CALL0 1128.92TRUE00
2025-12-1911589.5CALL0 1118.78TRUE00
2025-12-191200CALL0 0118.81TRUE00
2025-12-1912579.9CALL0 38109.57TRUE00
2025-12-191300CALL0 190.39TRUE00
2025-12-191350CALL0 192.15TRUE00
2025-12-191400CALL0 390.04TRUE00
2025-12-1914545.54CALL0 282.01TRUE00
2025-12-1915050.4CALL0 378.45TRUE00
2025-12-1915555.1CALL0 273.97TRUE00
2025-12-1916043.23CALL0 6766.36TRUE00
2025-12-1916543.79CALL0 161.35TRUE00
2025-12-1917041.5CALL0 20660.69TRUE00
2025-12-1917530CALL0 554.15TRUE00
2025-12-1918033.2CALL0 8852.16TRUE00
2025-12-1918526.5CALL0 3046.72TRUE00
2025-12-1919021.89CALL0 1743.66TRUE00
2025-12-1919521CALL0 20245.13TRUE00
2025-12-1920010.6CALL2 24148.49TRUE10.60
2025-12-192105.57CALL28 49535.69FALSE-0.43-0.07
2025-12-192202.62CALL418 47348.46FALSE0.340.15
2025-12-192301.3CALL0 135955.27FALSE00
2025-12-192401.45CALL0 77367.47FALSE00
2025-12-192501.4CALL0 6695.53FALSE00
2025-12-192601.47CALL0 111106.64FALSE00
2025-12-192701.1CALL0 12116.73FALSE00
2025-12-192800.8CALL0 8125.96FALSE00
2025-12-192900.25CALL0 11135.13FALSE00
2025-12-193000CALL0 0142.98FALSE00
2025-12-193100.5CALL0 2150.99FALSE00
2025-12-19600PUT0 0420.07FALSE00
2025-12-19650PUT0 1394.52FALSE00
2025-12-19700PUT0 0371.05FALSE00
2025-12-19750PUT0 0349.33FALSE00
2025-12-19800PUT0 20329.12FALSE00
2025-12-19850PUT0 1310.21FALSE00
2025-12-19900PUT0 21292.44FALSE00
2025-12-19950PUT0 1275.65FALSE00
2025-12-191000PUT0 1259.75FALSE00
2025-12-191052.1PUT0 3244.62FALSE00
2025-12-191102.65PUT0 4230.19FALSE00
2025-12-191150.6PUT0 0216.38FALSE00
2025-12-191200.85PUT0 2203.13FALSE00
2025-12-191251.05PUT0 0190.38FALSE00
2025-12-191300PUT0 1178.08FALSE00
2025-12-191351.1PUT0 1166.19FALSE00
2025-12-191400.6PUT0 76154.65FALSE00
2025-12-191450PUT0 1143.44FALSE00
2025-12-191500.7PUT0 6132.52FALSE00
2025-12-191550PUT0 0122.64FALSE00
2025-12-191601.16PUT0 3112.88FALSE00
2025-12-191651.24PUT0 7103.2FALSE00
2025-12-191701.27PUT0 31394.2FALSE00
2025-12-191751.34PUT0 1185.11FALSE00
2025-12-191800.7PUT0 1176.4FALSE00
2025-12-191851.7PUT0 46268.34FALSE00
2025-12-191902.85PUT0 49547.51FALSE00
2025-12-191951.5PUT1 48234.41FALSE-0.5-0.25
2025-12-192003.1PUT52 144745.76FALSE3.10
2025-12-192106.5PUT10 82443.7TRUE6.50
2025-12-1922019.9PUT0 16440.84TRUE00
2025-12-1923035.7PUT0 145.64TRUE00
2025-12-1924037.5PUT0 255.1TRUE00
2025-12-1925040.7PUT0 156.29TRUE00
2025-12-1926052.9PUT0 067.35TRUE00
2025-12-192700PUT0 073.92TRUE00
2025-12-1928076.5PUT0 075.5TRUE00
2025-12-1929081PUT0 00TRUE00
2025-12-1930083.9PUT0 00TRUE00
2025-12-193100PUT0 00TRUE00
2026-01-16750CALL0 0117.16TRUE00
2026-01-16800CALL0 0124TRUE00
2026-01-16850CALL0 0118.6TRUE00
2026-01-16900CALL0 0101.29TRUE00
2026-01-1695116CALL0 192.6TRUE00
2026-01-16100111CALL0 1100.29TRUE00
2026-01-161050CALL0 092.95TRUE00
2026-01-161100CALL0 088.49TRUE00
2026-01-161150CALL0 081.81TRUE00
2026-01-161200CALL0 077.65TRUE00
2026-01-161250CALL0 069.25TRUE00
2026-01-161300CALL0 063.34TRUE00
2026-01-1613545.5CALL0 163.62TRUE00
2026-01-161400CALL0 054.45TRUE00
2026-01-161450CALL0 052.83TRUE00
2026-01-1615037.5CALL0 052.85TRUE00
2026-01-161550CALL0 051.47TRUE00
2026-01-1616043.47CALL0 649.95TRUE00
2026-01-1616539.75CALL0 1750.75TRUE00
2026-01-1617036.8CALL0 21149.13TRUE00
2026-01-1617540.48CALL0 548.1TRUE00
2026-01-1618031.3CALL0 747.81TRUE00
2026-01-1618529.4CALL0 21546.84TRUE00
2026-01-1619022.89CALL0 1046.39TRUE00
2026-01-1619525.48CALL0 1045.41TRUE00
2026-01-1620018CALL4 8546.57TRUE180
2026-01-1621011.7CALL0 3044.53FALSE00
2026-01-162207.55CALL18 3046.75FALSE0.050.01
2026-01-162305.56CALL0 45046.04FALSE00
2026-01-162403.18CALL0 153545.43FALSE00
2026-01-162502.5CALL25 2650.8FALSE0.440.21
2026-01-162601.75CALL0 653.7FALSE00
2026-01-162700.6CALL0 470.38FALSE00
2026-01-162801.8CALL0 474.59FALSE00
2026-01-162900.5CALL0 278.91FALSE00
2026-01-163000CALL0 083.15FALSE00
2026-01-163100CALL0 087.01FALSE00
2026-01-16750PUT0 0197.21FALSE00
2026-01-16800PUT0 0185.83FALSE00
2026-01-16850PUT0 0175.18FALSE00
2026-01-16900PUT0 0165.17FALSE00
2026-01-16950PUT0 0155.72FALSE00
2026-01-161000PUT0 0146.76FALSE00
2026-01-161050PUT0 0138.25FALSE00
2026-01-161100.75PUT0 2130.12FALSE00
2026-01-161150PUT0 0122.35FALSE00
2026-01-161200PUT0 0114.88FALSE00
2026-01-161250PUT0 0107.71FALSE00
2026-01-161300PUT0 5100.78FALSE00
2026-01-161355.23PUT0 2794.09FALSE00
2026-01-161403.78PUT0 1988.13FALSE00
2026-01-161450PUT0 1482.29FALSE00
2026-01-161502.47PUT0 1077.02FALSE00
2026-01-161553.04PUT0 272.2FALSE00
2026-01-161604.1PUT0 1967.72FALSE00
2026-01-161656.8PUT0 2463.83FALSE00
2026-01-161701.95PUT0 2844.3FALSE00
2026-01-161752.84PUT0 1146.98FALSE00
2026-01-161803.58PUT2 1348.96FALSE3.580
2026-01-161854.36PUT0 22745.83FALSE00
2026-01-1619014.49PUT0 745.33FALSE00
2026-01-1619510.4PUT0 1044.29FALSE00
2026-01-162009.21PUT2 1244.65FALSE9.210
2026-01-1621013.65PUT1 242.13TRUE13.650
2026-01-162200PUT0 042.82TRUE00
2026-01-162300PUT0 042.93TRUE00
2026-01-162400PUT0 043.52TRUE00
2026-01-162500PUT0 044.22TRUE00
2026-01-1626066PUT0 046.96TRUE00
2026-01-1627059.8PUT0 049.85TRUE00
2026-01-1628076.3PUT0 052.11TRUE00
2026-01-1629092.6PUT0 053.71TRUE00
2026-01-1630090.6PUT0 00TRUE00
2026-01-163100PUT0 00TRUE00
2026-04-1710098.2CALL0 261.08TRUE00
2026-04-171050CALL0 058.05TRUE00
2026-04-1711086.9CALL0 155.09TRUE00
2026-04-1711588.6CALL0 056.53TRUE00
2026-04-171200CALL0 055.07TRUE00
2026-04-1712573.3CALL0 154.27TRUE00
2026-04-1713075.1CALL0 153.8TRUE00
2026-04-171350CALL0 053.15TRUE00
2026-04-171400CALL0 052.63TRUE00
2026-04-171450CALL0 051.89TRUE00
2026-04-1715061.7CALL0 151.63TRUE00
2026-04-171550CALL0 051.84TRUE00
2026-04-171600CALL0 051.67TRUE00
2026-04-171650CALL0 051.82TRUE00
2026-04-1717049.31CALL0 20051.36TRUE00
2026-04-1717539.62CALL0 1751.44TRUE00
2026-04-171800CALL0 051.35TRUE00
2026-04-171850CALL0 051.46TRUE00
2026-04-1719030.18CALL0 351.08TRUE00
2026-04-1719535.75CALL0 050.57TRUE00
2026-04-1720030CALL2 1153.45TRUE300
2026-04-1721025.47CALL2 2048.43FALSE25.470
2026-04-1722017CALL0 1546.39FALSE00
2026-04-1723014.7CALL1 5546.27FALSE14.70
2026-04-1724013.5CALL0 135043.97FALSE00
2026-04-172507.5CALL9 319741.32FALSE7.50
2026-04-172605CALL0 540.82FALSE00
2026-04-172704.7CALL0 039.25FALSE00
2026-04-172807.1CALL0 138.02FALSE00
2026-04-172901.75CALL1 537.67FALSE1.750
2026-04-173001.1CALL1 736.63FALSE1.10
2026-04-173100.8CALL1 336.84FALSE0.80
2026-04-173200CALL0 049.45FALSE00
2026-04-171000PUT0 083.52FALSE00
2026-04-171050PUT0 079.55FALSE00
2026-04-171102.15PUT0 175.33FALSE00
2026-04-171152.7PUT0 171.99FALSE00
2026-04-171200PUT0 068.7FALSE00
2026-04-171251.65PUT0 167.56FALSE00
2026-04-171302.1PUT0 165.57FALSE00
2026-04-171351.8PUT0 352.16FALSE00
2026-04-171402.1PUT0 351.29FALSE00
2026-04-171450PUT0 050.42FALSE00
2026-04-171500PUT0 050.5FALSE00
2026-04-171550PUT0 051.07FALSE00
2026-04-171600PUT0 052.26FALSE00
2026-04-171656PUT0 151.32FALSE00
2026-04-171706.6PUT0 20251.05FALSE00
2026-04-171750PUT0 050.9FALSE00
2026-04-1718011.6PUT0 250.85FALSE00
2026-04-1718516.07PUT0 15050.86FALSE00
2026-04-1719015.5PUT100 1049.6FALSE15.50
2026-04-171950PUT0 050FALSE00
2026-04-172000PUT0 049.38FALSE00
2026-04-172100PUT0 047.7TRUE00
2026-04-1722026.3PUT0 845.86TRUE00
2026-04-1723034.2PUT0 144.41TRUE00
2026-04-172400PUT0 041.8TRUE00
2026-04-172500PUT0 040.72TRUE00
2026-04-172600PUT0 039.33TRUE00
2026-04-172700PUT0 038.1TRUE00
2026-04-172800PUT0 036.25TRUE00
2026-04-1729079.69PUT0 037.22TRUE00
2026-04-1730093.64PUT0 00TRUE00
2026-04-17310103.51PUT0 00TRUE00
2026-04-173200PUT0 00TRUE00
2026-06-18800CALL0 060.49TRUE00
2026-06-18850CALL0 058.32TRUE00
2026-06-18900CALL0 057.15TRUE00
2026-06-18950CALL0 053.83TRUE00
2026-06-181000CALL0 055.31TRUE00
2026-06-181050CALL0 052.68TRUE00
2026-06-181100CALL0 052.7TRUE00
2026-06-181150CALL0 052.5TRUE00
2026-06-181200CALL0 052.46TRUE00
2026-06-181250CALL0 052.18TRUE00
2026-06-181300CALL0 051.23TRUE00
2026-06-181350CALL0 050.68TRUE00
2026-06-1814069.1CALL0 1150.75TRUE00
2026-06-181450CALL0 050.73TRUE00
2026-06-181500CALL0 050.31TRUE00
2026-06-1815551.5CALL0 250.56TRUE00
2026-06-1816049CALL0 249.9TRUE00
2026-06-1816553.9CALL0 249.83TRUE00
2026-06-1817037CALL0 1049.66TRUE00
2026-06-1817542.7CALL0 149.31TRUE00
2026-06-1818045.75CALL0 1748.9TRUE00
2026-06-1818531.8CALL0 148.72TRUE00
2026-06-1819035.5CALL0 1148.1TRUE00
2026-06-1819535.8CALL0 347.89TRUE00
2026-06-1820032CALL20 3346.56TRUE320
2026-06-1821030.17CALL0 1346.21FALSE00
2026-06-1822028.24CALL0 444.46FALSE00
2026-06-1823020CALL0 543.19FALSE00
2026-06-1824016.6CALL0 541.98FALSE00
2026-06-1825010.9CALL0 3840.76FALSE00
2026-06-1826010.2CALL0 740.28FALSE00
2026-06-182700CALL0 039.05FALSE00
2026-06-182800CALL0 038.9FALSE00
2026-06-182905.5CALL0 238FALSE00
2026-06-183002CALL0 237.62FALSE00
2026-06-183102.05CALL1 436.43FALSE2.050
2026-06-183201.4CALL1 035.52FALSE1.40
2026-06-18800PUT0 086.59FALSE00
2026-06-18850PUT0 082.11FALSE00
2026-06-18900PUT0 077.89FALSE00
2026-06-18950PUT0 073.88FALSE00
2026-06-181000PUT0 070.42FALSE00
2026-06-181050PUT0 067.41FALSE00
2026-06-181100PUT0 064.77FALSE00
2026-06-181150PUT0 062.96FALSE00
2026-06-181200PUT0 060.8FALSE00
2026-06-181252.31PUT0 250.52FALSE00
2026-06-181309.08PUT0 049.87FALSE00
2026-06-181350PUT0 049.34FALSE00
2026-06-181400PUT0 049.74FALSE00
2026-06-181454.3PUT0 149.62FALSE00
2026-06-181505.2PUT0 349.65FALSE00
2026-06-181556.1PUT0 249.5FALSE00
2026-06-1816016.2PUT0 249.39FALSE00
2026-06-1816512PUT0 349.07FALSE00
2026-06-1817013.2PUT0 848.91FALSE00
2026-06-1817514PUT0 4548.44FALSE00
2026-06-1818033.3PUT0 948.32FALSE00
2026-06-1818535.6PUT0 847.92FALSE00
2026-06-181900PUT0 047.17FALSE00
2026-06-1819530.4PUT0 147.01FALSE00
2026-06-1820044.5PUT0 246.42FALSE00
2026-06-1821038.5PUT0 145.06TRUE00
2026-06-182200PUT0 043.8TRUE00
2026-06-182300PUT0 042.42TRUE00
2026-06-182400PUT0 041.27TRUE00
2026-06-182500PUT0 039.92TRUE00
2026-06-1826090.48PUT0 26939.03TRUE00
2026-06-182700PUT0 037.88TRUE00
2026-06-182800PUT0 037.17TRUE00
2026-06-182900PUT0 036.05TRUE00
2026-06-183000PUT0 00TRUE00
2026-06-1831098.75PUT0 00TRUE00
2026-06-18320108.7PUT0 00TRUE00
2026-07-171050CALL0 049.25TRUE00
2026-07-171100CALL0 049.16TRUE00
2026-07-171150CALL0 050TRUE00
2026-07-171200CALL0 049.75TRUE00
2026-07-171250CALL0 048.82TRUE00
2026-07-1713078.3CALL0 049.67TRUE00
2026-07-171350CALL0 049.31TRUE00
2026-07-1714070.3CALL0 049.64TRUE00
2026-07-171450CALL0 049.53TRUE00
2026-07-171500CALL0 049.63TRUE00
2026-07-171550CALL0 049.76TRUE00
2026-07-171600CALL0 049.31TRUE00
2026-07-171650CALL0 049.28TRUE00
2026-07-171700CALL0 049.38TRUE00
2026-07-171750CALL0 049.1TRUE00
2026-07-1718042.35CALL0 148.95TRUE00
2026-07-171850CALL0 048.58TRUE00
2026-07-171900CALL0 048.07TRUE00
2026-07-171950CALL0 047.63TRUE00
2026-07-172000CALL0 047.14TRUE00
2026-07-1721025.5CALL0 146.17FALSE00
2026-07-172200CALL0 044.92FALSE00
2026-07-172300CALL0 043.56FALSE00
2026-07-172400CALL0 042.47FALSE00
2026-07-172500CALL0 041.13FALSE00
2026-07-172600CALL0 039.85FALSE00
2026-07-172700CALL0 038.98FALSE00
2026-07-172800CALL0 038.49FALSE00
2026-07-172900CALL0 037.65FALSE00
2026-07-173000CALL0 037.23FALSE00
2026-07-173102.4CALL0 236.27FALSE00
2026-07-173201.65CALL0 236.17FALSE00
2026-07-173300CALL0 047.12FALSE00
2026-07-171050PUT0 062.16FALSE00
2026-07-171100PUT0 059.77FALSE00
2026-07-171151.2PUT1 047.21FALSE1.20
2026-07-171201.55PUT1 046.84FALSE1.550
2026-07-171252PUT0 146.77FALSE00
2026-07-171302.5PUT0 148.12FALSE00
2026-07-171350PUT0 048.16FALSE00
2026-07-171400PUT0 048.73FALSE00
2026-07-171450PUT0 048.79FALSE00
2026-07-171500PUT0 048.95FALSE00
2026-07-171550PUT0 049FALSE00
2026-07-171600PUT0 048.83FALSE00
2026-07-171650PUT0 048.49FALSE00
2026-07-171700PUT0 048.61FALSE00
2026-07-171750PUT0 048.25FALSE00
2026-07-171800PUT0 048.02FALSE00
2026-07-171850PUT0 047.37FALSE00
2026-07-171900PUT0 047.3FALSE00
2026-07-171950PUT0 047FALSE00
2026-07-172000PUT0 046.4FALSE00
2026-07-172100PUT0 045.32TRUE00
2026-07-172200PUT0 044.15TRUE00
2026-07-172300PUT0 042.73TRUE00
2026-07-172400PUT0 041.32TRUE00
2026-07-172500PUT0 040.65TRUE00
2026-07-172600PUT0 039.5TRUE00
2026-07-172700PUT0 038.48TRUE00
2026-07-1728074.8PUT0 137.03TRUE00
2026-07-172900PUT0 035.71TRUE00
2026-07-1730093.1PUT0 135.59TRUE00
2026-07-173100PUT0 00TRUE00
2026-07-17320111.3PUT0 00TRUE00
2026-07-173300PUT0 00TRUE00
2026-12-181000CALL0 054.04TRUE00
2026-12-181050CALL0 052.45TRUE00
2026-12-181100CALL0 052.72TRUE00
2026-12-181150CALL0 052.6TRUE00
2026-12-181200CALL0 052.19TRUE00
2026-12-181250CALL0 051.56TRUE00
2026-12-181300CALL0 050.76TRUE00
2026-12-181350CALL0 050.99TRUE00
2026-12-181400CALL0 050.94TRUE00
2026-12-181450CALL0 050.17TRUE00
2026-12-181500CALL0 050.22TRUE00
2026-12-181550CALL0 049.61TRUE00
2026-12-181600CALL0 048.88TRUE00
2026-12-181650CALL0 048.84TRUE00
2026-12-181700CALL0 048.63TRUE00
2026-12-181750CALL0 048.27TRUE00
2026-12-181800CALL0 047.78TRUE00
2026-12-181850CALL0 047.86TRUE00
2026-12-181900CALL0 047.45TRUE00
2026-12-181950CALL0 046.93TRUE00
2026-12-182000CALL0 046.62TRUE00
2026-12-1821042CALL0 1046.29FALSE00
2026-12-1822031.25CALL0 244.9FALSE00
2026-12-182300CALL0 043.71FALSE00
2026-12-182400CALL0 042.72FALSE00
2026-12-182500CALL0 041.33FALSE00
2026-12-182600CALL0 040.12FALSE00
2026-12-182700CALL0 039.11FALSE00
2026-12-182800CALL0 038.42FALSE00
2026-12-182900CALL0 037.81FALSE00
2026-12-1830010.6CALL0 6437.42FALSE00
2026-12-183100CALL0 036.91FALSE00
2026-12-183200CALL0 036.39FALSE00
2026-12-181000PUT0 062.55FALSE00
2026-12-181052.67PUT0 548.95FALSE00
2026-12-181103.28PUT0 548.28FALSE00
2026-12-181150PUT0 048.97FALSE00
2026-12-181200PUT0 049.17FALSE00
2026-12-181250PUT0 049.15FALSE00
2026-12-181300PUT0 048.98FALSE00
2026-12-181350PUT0 048.69FALSE00
2026-12-181400PUT0 048.29FALSE00
2026-12-181450PUT0 048.32FALSE00
2026-12-181500PUT0 048.22FALSE00
2026-12-181550PUT0 048FALSE00
2026-12-181600PUT0 047.77FALSE00
2026-12-181650PUT0 047.53FALSE00
2026-12-181700PUT0 047.59FALSE00
2026-12-181750PUT0 046.74FALSE00
2026-12-181800PUT0 046.49FALSE00
2026-12-181850PUT0 046.79FALSE00
2026-12-181900PUT0 046.25FALSE00
2026-12-181950PUT0 046.24FALSE00
2026-12-182000PUT0 045.45FALSE00
2026-12-182100PUT0 044.79TRUE00
2026-12-182200PUT0 043.65TRUE00
2026-12-182300PUT0 042.65TRUE00
2026-12-182400PUT0 041.78TRUE00
2026-12-182500PUT0 040.42TRUE00
2026-12-182600PUT0 039.12TRUE00
2026-12-182700PUT0 038.68TRUE00
2026-12-182800PUT0 037.58TRUE00
2026-12-182900PUT0 037.56TRUE00
2026-12-183000PUT0 036.95TRUE00
2026-12-183100PUT0 036.72TRUE00
2026-12-183200PUT0 035.44TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm